Progression of brain tumor stem cell markers

doi:10.3760/cma.j.issn.1673-422X.2014.12.007

Abstract

WU Bin, XIA Liang. Progression of brain tumor stem cell markers[J]. Journal of International Oncology, 2014, 41(12): 899-901.

［1］ Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice［J］. Nature, 1994, 367(6464): 645648. ［2］ Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells［J］. Blood, 1997, 90(12): 50025012. ［3］ Shmelkov SV, Jun L, St Clair R, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133［J］. Blood, 2004, 103(6): 20552061. ［4］ Yu Y, Flint A, Dvorin EL, et al. AC1332, a novel isoform of human AC133 stem cell antigen［J］. J Biol Chem, 2002, 277(23): 2071120716. ［5］ Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells［J］. Nature, 2004, 432(7015): 396401. ［6］ Singh S, Dirks PB. Brain tumor stem cells: identification and concepts［J］. Neurosurg Clin N Am, 2007, 18(1): 3138, viii. ［7］ He H, Li MW, Niu CS. The pathological characteristics of glioma stem cell niches［J］. J Clin Neurosci, 2012, 19(1): 121127. ［8］ Kahlert UD, Bender NO, Maciaczyk D, et al. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cellrelated gene expression profile in in vitro propagated glioblastoma multiformederived cell line with a PNETlike component［J］. Folia Neuropathol, 2012, 50(4): 357368. ［9］ Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response［J］. Nature, 2006, 444(7120): 756760. ［10］ Neuzil J, Tomasetti M, Zhao Y, et al. Vitamin E analogs, a novel group of "mitocans," as anticancer agents: the importance of being redoxsilent［J］. Mol Pharmacol, 2007, 71(5): 11851199. ［11］ Wu A, Wiesner S, Xiao J, et al. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy［J］. J Neurooncol, 2007, 83(2): 121131. ［12］ Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133() glioblastomaderived cancer stem cells show differential growth characteristics and molecular profiles［J］. Cancer Res, 2007, 67(9): 40104015. ［13］ Joo KM, Kim SY, Jin X, et al. Clinical and biological implications of CD133positive and CD133negative cells in glioblastomas［J］. Lab Invest, 2008, 88(8): 808815. ［14］ Cattaneo E, McKay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor［J］. Nature, 1990, 347(6295): 762765. ［15］ Tohyama T, Lee VM, Rorke LB, et al. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells［J］. Lab Invest, 1992, 66(3): 303313. ［16］ Rutka JT, Ivanchuk S, Mondal S, et al. Coexpression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells［J］. Int J Dev Neurosci, 1999, 17(56): 503515. ［17］ Schiffer D, Manazza A, Tamagno I. Nestin expression in neuroepithelial tumors［J］. Neurosci Lett, 2006, 400(12): 8085. ［18］ Chang ZG, Yang LY, Wang W, et al. Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker［J］. Dig Dis Sci, 2005, 50(10): 17641770. ［19］ Manivannan P, Siddaraju N, Jatiya L, et al. Role of proangiogenic marker galectin3 in follicular neoplasms of thyroid［J］. Indian J Biochem Biophys, 2012, 49(5): 392394. ［20］ Goldammer T, Owens E, Brunner RM, et al.Assignment of syndecan 2 (SDC2)gene to cattle chromosome band 14q22 and thymus high mobility group box protein TOX (TOX)(2) gene to cattle chromosome band 14q17q18 by in situ hybridization［J］. Cytogenet Genome Res, 2002, 98(4): 311B. ［21］ Zhang Y, Ma T, Yang S, et al. Highmobility group A1 proteins enhance the expression of the oncogenic miR222 in lung cancer cells［J］. Mol Cell Biochem, 2011, 357(12): 363371. ［22］ Rho YS, Lim YC, Park IS, et al. High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma［J］. Acta Otolaryngol, 2007, 127(1):7681. ［23］ Fan H, Guo H, Zhang IY, et al. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251［J］. Brain Res, 2011, 1384: 914. ［24］ Donato G, Martinez Hoyos J, Amorosi A, et al. High mobility group A1 expression correlates with the histological grade of human glial tumors［J］. Oncol Rep, 2004, 11(6): 12091213. ［25］ Ogawa S, Tokumoto Y, Miyake J, et al. Immunopanning selection of A2B5positive cells increased the differentiation efficiency of induced pluripotent stem cells into oligodendrocytes［J］. Neurosci Lett, 2011, 489(2): 7983. ［26］ Baracskay KL, Kidd GJ, Miller RH, et al. NG2positive cells generate A2B5positive oligodendrocyte precursor cells［J］. Glia, 2007, 55(10): 10011010. ［27］ Ogden AT, Waziri AE, Lochhead RA, et al. Identification of A2B5+CD133- tumorinitiating cells in adult human gliomas［J］. Neurosurgery, 2008, 62(2): 505514. ［28］ Tchoghandjian A, Baeza N, Colin C, et al. A2B5 cells from human glioblastoma have cancer stem cell properties［J］. Brain Pathol, 2010, 20(1): 211221. ［29］ Xu M, Yao Y, Hua W, et al. Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysatepulsed dendritic cells［J］. Neurooncol, 2014, 116(3): 497504.

[1]	Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei. Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction [J]. Journal of International Oncology, 2024, 51(4): 193-197.
[2]	Xiao Nan, Sun Pengfei. Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas [J]. Journal of International Oncology, 2022, 49(6): 357-361.
[3]	Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao. Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients [J]. Journal of International Oncology, 2022, 49(2): 79-83.
[4]	Kong Chunyu, Sun Pengfei. SLC7A11 and glioma [J]. Journal of International Oncology, 2022, 49(10): 604-607.
[5]	Guo Shihao, Ren Yeqing, Guo Geng. Molecular mechanism of vasculogenic mimicry in brain glioma [J]. Journal of International Oncology, 2021, 48(6): 362-365.
[6]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei. Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis [J]. Journal of International Oncology, 2021, 48(4): 193-199.
[7]	Wei Yongjian, Hu Jinjing, Li Xun. Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells [J]. Journal of International Oncology, 2021, 48(4): 216-219.
[8]	Sun Yanqi, Ren Yeqing, Guo Geng. Mechanism of inhibitory effect of interferon and its related signal pathway on the invasion of glioma [J]. Journal of International Oncology, 2021, 48(3): 172-175.
[9]	Zhao Congxuan, Yu Tao. Mining and prediction of glioma-related genes [J]. Journal of International Oncology, 2020, 47(5): 293-296.
[10]	Nan Yang, Zhong Yue. New research advances of long non-coding RNA in glioma [J]. Journal of International Oncology, 2020, 47(2): 98-102.
[11]	Zhang Wen, Song Qibin, Hu Weiguo. Clinical application of multimodal magnetic resonance imaging in glioma [J]. Journal of International Oncology, 2020, 47(11): 686-690.
[12]	Chen Liang, Qin Jun, Lei Junrong, Liu Jun, Wang Lu. miR-1254 inhibits the proliferation and invasion of glioma cells by targeting CSF-1 [J]. Journal of International Oncology, 2020, 47(10): 577-584.
[13]	Zhang Qianhui, Zhang Yang, Su Weipeng, Zhang Song′an, Liu Pan, Zhao Huarong. Expressions of LSD1, MGMT and Ki-67 in high-grade glioma and their influences on prognosis [J]. Journal of International Oncology, 2019, 46(9): 519-525.
[14]	Yi Lin, Qiu Shi. Anti-tumor effect and mechanisms of shikonin on gliomas [J]. Journal of International Oncology, 2019, 46(8): 489-491.
[15]	Kang Ye, Li Jianyi, Yang Xianghong. Research progress of cancer stem cells in triplenegative breast cancer [J]. Journal of International Oncology, 2019, 46(6): 362-365.

Progression of brain tumor stem cell markers

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments